McKesson Corporation (MCK)
NYSE·Healthcare·Medical - Distribution
$837.30
+1.08%
Mkt Cap $106.03B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 4, 2026 | $105.80B | $106.16B | +0.34% | $9.17 | $9.34 | +1.85% | — | — |
| Q4 2025 Nov 5, 2025 | $104.14B | $103.15B | -0.95% | $9.03 | $9.86 | +9.19% | — | — |
| Q3 2025 Aug 6, 2025 | $96.18B | $97.83B | +1.71% | $8.14 | $8.26 | +1.47% | — | — |
| Q2 2025 May 8, 2025 | $94.30B | $90.82B | -3.69% | $9.83 | $10.12 | +2.95% | — | — |
| Q1 2025 Feb 5, 2025 | $96.05B | $95.29B | -0.79% | $8.60 | $8.03 | -6.63% | — | — |
| Q4 2024 Nov 6, 2024 | $89.33B | $93.65B | +4.84% | $6.88 | $7.07 | +2.76% | — | — |
| Q3 2024 Aug 7, 2024 | $82.53B | $79.28B | -3.94% | $7.21 | $7.88 | +9.29% | — | — |
| Q2 2024 May 7, 2024 | $79.32B | $76.36B | -3.74% | $6.34 | $6.18 | -2.52% | — | — |
| Q1 2024 Feb 7, 2024 | $77.93B | $80.90B | +3.80% | $7.04 | $7.74 | +9.94% | — | — |
| Q4 2023 Nov 1, 2023 | $75.96B | $77.22B | +1.65% | $6.15 | $6.23 | +1.30% | — | — |
| Q3 2023 Aug 2, 2023 | $70.28B | $74.48B | +5.98% | $5.87 | $7.27 | +23.85% | — | — |
| Q2 2023 May 8, 2023 | $68.08B | $68.91B | +1.21% | $7.17 | $7.19 | +0.28% | — | — |
| Q1 2023 Feb 1, 2023 | $71.04B | $70.49B | -0.78% | $6.35 | $6.90 | +8.66% | — | — |
| Q4 2022 Nov 1, 2022 | $70.25B | $70.16B | -0.13% | $6.09 | $6.06 | -0.49% | — | — |
| Q3 2022 Aug 3, 2022 | $64.92B | $67.15B | +3.45% | $5.28 | $5.83 | +10.42% | — | — |
| Q2 2022 May 5, 2022 | $63.68B | $66.10B | +3.81% | $6.06 | $5.83 | -3.80% | — | — |
| Q1 2022 Feb 2, 2022 | $66.62B | $68.61B | +2.99% | $5.38 | $6.15 | +14.31% | — | — |
| Q4 2021 Nov 1, 2021 | $63.22B | $66.58B | +5.31% | $4.67 | $6.15 | +31.69% | — | — |
| Q3 2021 Aug 4, 2021 | $62.67B | $62.67B | +0.00% | $4.09 | $5.56 | +35.94% | — | — |
| Q2 2021 May 6, 2021 | $59.02B | $59.14B | +0.20% | $5.04 | $5.05 | +0.20% | — | — |